Astrazeneca AZN
NYSE AZN
$156.91 -0.77 (-0.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

Astrazeneca (AZN) Accumulated Expenses (2018 - 2021)

Updated

Astrazeneca (AZN) recorded Accumulated Expenses of -$911 million in Q1 2021.

Analysis

Astrazeneca (AZN) Accumulated Expenses (2018 - 2021) Analysis & Trends

At the end of FY2020, Astrazeneca reported Accumulated Expenses of $1.08 billion, up 21.5% from FY2019.

  • Across earlier years, Accumulated Expenses came in at $892.7 million in FY2019 and $7 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Vertex Pharmaceuticals 127.87 Bn 99.88 Bn 2.84 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -911.00 Mn
Dec 31, 2020 1.08 Bn
Dec 31, 2019 892.70 Mn
Dec 31, 2018 7.00 Mn
API Access

Astrazeneca Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=AZN&period=max&api_key=YOUR_API_KEY